Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the cdc50Δ Mutant Susceptibility for Lead Compound Development

Microbiology Spectrum(2022)10.1128/spectrum.00439-22Source: DataRank Database

Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the cdc50Δ Mutant Susceptibility for Lead Compound Development is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.76)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yina Wang ORCID,Siddhi Pawar,Chaoyang Xue ORCID,Gregory Wiedman ORCID,Robert J. Tancer ORCID

Live enrichment

PubMed:35377230 PMC:PMC9045296 OpenAlex:https://openalex.org/W4225089644

HHS | National Institutes of Health

Grant: R21AI154318

HHS | National Institutes of Health

Grant: R01123315

NIAID NIH HHS

Grant: R01 AI155647

NIAID NIH HHS

Grant: R01 AI123315

National Institutes of Health

Grant: 5R21AI154318-02

Lipid flippase in echinocandin drug resistance in Cryptococcus neoformans

FWCI

1.76

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.00439-22

publisherhttps://doi.org/10.1128/spectrum.00439-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.00439-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35377230

repositoryhttps://doaj.org/article/2f999b14194c48ab9b91d6c7cda27b1f

Fields of Study

Fungal Infections and StudiesAntimicrobial Peptides and ActivitiesAntifungal resistance and susceptibility0301 basic medicine0303 health sciences03 medical and health sciencesAdenosine TriphosphatasesAntifungal AgentsCaspofunginCryptococcosisCryptococcus neoformansEchinocandinsLeadMicrobial Sensitivity TestsPeptides

MeSH Terms

CaspofunginAdenosine TriphosphatasesAntifungal AgentsCryptococcosisCryptococcus neoformansLeadMicrobial Sensitivity TestsPeptidesEchinocandins

Keywords

Cryptococcus neoformansAntifungalCryptococcusMutantLead compoundMicrobiologyAntifungal drugDrug developmentOrganismBiologyPeptideDrugFungal proteinComputational biologyChemistryBiochemistryIn vitroPharmacologyGeneGeneticsFungiResistanceLead compoundsAntimicrobial agentsmutantsAntimicrobial peptidesFungal MeningitisImmunocompromised HostsDrug SynergyAdenosine TriphosphatasesAntifungal AgentsCryptococcosisMicrobial Sensitivity TestsQR1-502EchinocandinsLeadCaspofunginPeptidesResearch Article

Sustainable Development Goals

SDG 3: 3. Good health

Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the cdc50Δ Mutant Susceptibility for Lead Compound Development

FAIR Checklist

Authors (5)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)